prevalence ratios of ischemic heart disease, atherosclerosis, and cerebrovascular disease were 1.2, 1.5, and 1.7, respectively, in AS in comparison to healthy controls 11 . There may be a 4.4-fold increased risk for myocardial infarction in AS 8 . The basic mechanisms of accelerated atherosclerosis and cardiovascular disease in AS are similar to those associated with RA 1, 4, 5 . Among traditional Framingham risk factors, AS has been associated with high prevalence of metabolic syndrome including dyslipidemia, high ratio of low-density lipoprotein cholesterol (LDL-C) to high-density lipoprotein cholesterol (HDL-C), and hyperhomocysteinemia 12, 24 . However, inflammatory mechanisms underlying AS may be the key factors that lead to atherosclerosis and vascular disease. Sustained systemic inflammation in AS is accompanied by elevated serum levels of C-reactive protein (CRP), an acute-phase protein with proatherogenic effects 13, 17 . Proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) may also be involved in this process, and TNF blockade leads to the improvement of lipid profile in AS 19 . TNF-α and CRP have been implicated in impaired coronary flow reserve and left ventricular diastolic function in AS 10 .
Noninvasive angiological methods have been developed to evaluate endothelial and vascular function in rheumatic as well as autoimmune diseases. Flow-mediated vasodilation (FMD), common carotid intima-media thickness (ccIMT), and pulse-wave velocity (PWV) are reliable indicators of endothelium-dependent vascular function, overt atherosclerosis, and arterial stiffness, respectively. We and others have used these techniques to assess abnormalities of vascular function in RA 3, 25, 26, 27 . Similar methods can be applied to detect endothelial dysfunction, atherosclerosis, and vascular stiffness in AS 6, 7, 8, 10, 13, 15, 17 . There have been relatively few and somewhat controversial data regarding vascular function in AS 23 . There is a 1.5-times higher risk for atherosclerosis, a 1.2 to 4.4-times higher risk for ischemic heart disease, a 1.6-times higher risk for peripheral vascular disease, and a 1.7-times higher risk for cerebrovascular disease in AS. This increased risk is comparable to that reported in RA (1.9, 1.5, 2.4, and 1.6-times risk, respectively) 8, 11 . Chronic inflammation may be the major risk factor for atherosclerosis in AS 14, 23 , as well as in other arthritides 1, 4, 5, 14 .
There have been recent studies that separately assessed FMD, ccIMT, or PWV in AS. Endothelial dysfunction indicated by impaired FMD has been reported by Sari, et al 17 in a cohort of 54 patients with AS. Impaired FMD did not correlate with age, sex, CRP, erythrocyte sedimentation rate (ESR), smoking habits, or disease activity. Pieringer 15 also published preliminary results on impaired FMD in AS.
Sari, et al 17 also assessed ccIMT in the same cohort and found no differences between AS and the control group. Other groups, such as Malesci, et al 12 and Choe, et al 6 , also reported normal ccIMT in cohorts of 24 to 28 patients with AS in comparison to healthy subjects. Gonzalez-Juanatey, et al 7 assessed ccIMT and carotid plaques in 64 patients with AS. Carotid plaques were more commonly observed in AS compared to controls. But no differences in ccIMT were observed. In contrast to these reports, Mathieu, et al 13 reported a marginal, nonsignificant increase of ccIMT in 60 patients with AS compared to controls. Finally, Peters, et al 8 assessed 59 patients with AS and found significantly higher ccIMT in the patients in comparison to controls even after adjustment for traditional cardiovascular risk factors.
Regarding arterial stiffness, Choe, et al 6 estimated elastic properties including distensibility, stiffness index, and incremental elastic modulus, but not PWV, in 28 patients with AS. Arterial elastic measurements did not differ between patients with AS and controls. Moyssakis, et al 28 evaluated aortic distensibility and reported impaired elasticity in AS. Mathieu, et al 13 determined the augmentation index (AIx), another indicator of arterial stiffness, in 60 patients with AS and controls. There was a trend toward increased arterial stiffness in AS in comparison to controls; however, this difference was not statistically significant. To date, none of the investigators have reported data on PWV, a standard indicator of arterial stiffness in AS.
All these studies showed data from separate assessments of FMD, ccIMT, and elasticity. Only Sari, et al 17 investigated FMD and ccIMT simultaneously, but they did not assess vascular stiffness. There have been no reports on PWV in AS. In addition, none of the investigators assessed the 3 vascular measurements (FMD, ccIMT, and PWV) together and also in association with numerous other clinical and laboratory measurements.
Therefore, we conducted a complex study and assessed FMD, ccIMT, and PWV in the same cohort of patients with AS. In addition, we correlated vascular function with several other clinical and laboratory measurements including age, disease duration, smoking, body mass index (BMI), disease activity, pain intensity determined by the patient [visual analog scale (VAS)], Bath AS Disease Activity Index (BAS-DAI), lumbar spine mobility, chest expansion, wall-occiput distance, Bath AS Functional Index (BASFI), CRP, ESR, and HLA-B27 status. Ours may be the first study that investigated endothelial function, atherosclerosis, and arterial stiffness in the same patient cohort and correlated these markers with numerous other indicators.
MATERIALS AND METHODS
Patients. The study patient group was 43 patients with AS [31 men (72%), 12 women (28%); mean age 45.4 ± 11.8 yrs, range 26-75 years; all white; Table 1 ]. The diagnosis of AS was based on the modified New York criteria 29 . Among the 43 patients, 33 (76.7%) had only axial involvement, while 10 (23.3%) also had peripheral arthritis. There were 36 patients (83.7%) who were HLA-B27-positive. Fourteen of the 43 patients (32.6%) were in an active state of disease (BASDAI > 40) 30 . Most patients (37/43, 86%) received nonsteroidal antiiflammatory drugs (NSAID). The possible cardiovascular effects of NSAID cannot be fully ruled out; however, as none of the patients with AS had clinical cardiovascular disease, this possible effect was not observed on the clinical level. Among the 10 patients with AS who had peripheral involvement, 6 (60%) received conventional dis-ease-modifying antirheumatic drugs (DMARD) including methotrexate or sulfasalazine. Twenty-eight patients (65.1%) took anti-TNF biologics. We recruited 40 age-matched and sex-matched healthy control subjects from volunteer hospital workers, visitors, and relatives [27 men (67.5%) and 13 women (32.5%); mean age 48.2 ± 13.2 yrs, range 24-80 yrs; all white]. None of the patients with AS received systemic or local corticosteroids at the time of or at least 3 months prior to our study. None of the patients or controls received any vasoactive drugs or anticoagulants, such as aspirin, clopidogrel, heparin, warfarin/acenocoumarol, statins, angiotensin-converting enzyme inhibitors, or calcium channel blockers.
Each participant gave informed consent, according to the Declaration of Helsinki. For our study we also obtained local ethical committee approval at the University of Debrecen. Serum samples were then obtained from all subjects and kept frozen at -70°C until further use.
Clinical and laboratory measurements. The age, disease duration, and BMI of all patients with AS were recorded. Pain intensity and disease activity were determined by the patient on a 10-cm VAS. Disease activity and functional capacity mobility were also tested by obtaining BASDAI and BASFI, respectively. Metric measurements including lumbar spine mobility were assessed by Schober's test; chest expansion and wall-occiput distance were also recorded.
Among laboratory indicators, ESR (mm/h) was assessed by the Westergren method. Serum CRP (mg/l) was measured by quantitative nephelometry (Roche Cobas Mira Plus, Block Scientific, Bohemia, NY, USA), using CRP reagents (Dialab, Vienna, Austria). After overnight fasting, blood samples were taken from the patients and controls for serum glucose, total cholesterol, LDL-C, HDL-C, triglyceride, renal and liver function tests, and full blood count. Urine samples were tested by Uricont-S. HLA-B27 genotyping was performed using polymerase chain reaction-sequence-specific primer technique (Histo Type B27 high resolution kit, BAG, Lich, Germany). Assessment of possible cardiovascular involvement and study inclusion criteria. All patients with AS and healthy controls had a negative history for previous cardiovascular, cerebrovascular, or peripheral arterial disease. The AS and control groups were comparable in lipid levels, BMI, blood pressure, and other traditional cardiovascular risk factors ( Table 2 ). Thirteen of the 43 patients with AS (30.2%) and 14 of 40 controls (35.0%) were current smokers. We applied the cutoff points published by Pedersen, et al 31 in RA (≥ 20 pack-years). Cumulative tobacco intake was also calculated by multiplying the mean daily intake by the duration of consumption in years. Patients with traditional cardiovascular risk factors other than smoking, such as hypertension (blood pressure > 140/90 mm Hg), diabetes mellitus, and those with any vasculitis, current infectious disease or renal failure (serum creatinine ≥ 117 mmol/l) were excluded. Cardiovascular involvement was also assessed by electrocardiogram (ECG) and echocardiography performed in all patients and controls. Based on all these data, all patients with AS or controls were considered free of clinically relevant vascular disease.
Assessment of brachial artery FMD. Brachial FMD and nitroglycerin-mediated vasodilation were assessed as described by us and others 25, 32 . Ultrasound examination was performed on the right arm using a 10 MHz linear array transducer (HP Sonos 5500 ultrasound system) by a single trained sonographer after 30 min resting in a temperature-controlled room (basal value for FMD). A B-mode longitudinal section was obtained of the brachial artery above the antecubital fossa. In order to assess FMD, reactive hyperemia was induced by release of a pneumatic cuff around the forearm inflated to suprasystolic pressure for 4.5 min. After deflation, the maximal flow velocity and the arterial diameter was continuously recorded for 90 min. Flow velocities, the baseline diameter, and FMD were ECGgated and detected offline. Three repeated FMD measurements were performed on each patient or control subject. Mean FMD values were expressed as percent change from baseline (resting) value.
Determination of common carotid atherosclerosis. The ccIMT measurements were carried out as described by us and others 25, 33 . A duplex ultrasound system (HP Sonos 5500, 10 MHz linear array transducer) was used to assess the common carotid arteries by a single observer. Longitudinal high-resolution B-mode ultrasound scans were employed over both right and left common carotid arteries and were R-synchronized and recorded. The offline measurements were performed 1 cm proximal to the carotid bulb in the far wall. Sites of carotid plaques were avoided. The ccIMT was defined as the distance between the first and second echogenic lines from the lumen, taking the average of 10 measurements on both sides. Values of ccIMT were expressed in mm.
Assessment of PWV. Determination of arterial stiffness was carried out after a modification of our validated technique 26 
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The Journal of on April 2, 2020 -Published by www.jrheum.org Downloaded from based on the contraction of the myocardium initiating pulse waves in the aorta. The first wave becomes reflected from the aortic wall at the bifurcation; therefore a second, reflected wave appears as a late systolic peak. The morphology of this second, reflected wave depends on the stiffness of the large artery. Thus, we acquired suprasternal and femoral images and pulse-wave Doppler signals (HP Sonos 5500, 2-4 MHz phased array and 5-10 MHz linear array transducers). Simultaneous ECG recording was performed. ECG-gated Doppler analyses were performed over the beginning of the descending aorta and over the common femoral artery at the level of the inguinal ligament. Pulse-wave Doppler signals were recorded over 10 cardiac cycles at 150 mm/s sweep speed. Distances between the suprasternal notch and the 2 sampling sites were also measured and pulse transit times were recorded. The time delay was derived from the difference between the 2 transit times and PWV in m/s was calculated as distance divided by time delay.
In order to have reproducible results, all subjects needed a rest for at least 5 min prior to FMD and PWV assessments.
Statistical analysis and reproducibility. For the analysis of FMD and PWV, Kolmogorov-Smirnov and Lilliefors tests were used. Subsequently we performed correlation analyses. In cases of normal distribution (parametric), Pearson's test was performed, while in cases of non-normal distribution (nonparametric), Spearman's test was performed. R values of these correlations were determined and corresponding p values < 0.05 were considered significant.
Regarding reproducibility, all assessments were performed by a single observer. Intraobserver variability of FMD, ccIMT, and PWV measurements were calculated as 5%, 4.2%, and 3.3%, respectively. The "stability" of measurements is indicated by the reproducibility for month-to-month repeated assessments of FMD, ccIMT, or PWV. According to the Brand-Altman analysis, the 95% limits of agreement ranged between -1.6% and 1.9% for all assessments.
RESULTS

Assessment of FMD, ccIMT, and PWV.
In order to assess endothelial function, brachial artery FMD was measured by high-resolution ultrasonography. FMD in patients with AS expressed in percentage of the basal value was significantly lower (6.85 ± 2.98%) in comparison to controls (8.30 ± 3.96%; p = 0.005; Figure 1A) . A duplex ultrasound system was used to assess ccIMT. In patients with AS (0.65 ± 0.15 mm), ccIMT was significantly higher in comparison to controls (0.54 ± 0.15 mm; p = 0.01; Figure 1B) .
PWV, an indicator of aortic stiffness, was significantly increased in patients with AS (8.64 ± 2.44 m/s) in comparison to controls (8.00 ± 1.46 m/s; p = 0.03; Figure 1C ).
Correlations between FMD, ccIMT, PWV, and clinical and laboratory markers in patients with AS.
In patients with AS, values of FMD, ccIMT, and PWV were correlated with each other, as well as with other clinical and laboratory indicators ( Table 2) .
FMD and ccIMT negatively correlated with each other (r = -0.563; p = 0.0001). PWV also correlated with ccIMT (r = 0.374; p = 0.018; Table 3 ).
Both ccIMT and PWV exerted positive correlations with disease duration (r = 0.559; p = 0.013 and r = 0.520; p = 0.022, respectively), but FMD did not. PWV also correlated with age (r = 0.382; p = 0.016). Higher ccIMT or PWV also correlated with increased BASFI (r = 0.691; p = 0.003 and r = 0.654; p = 0.006), negatively correlated with lumbar spine mobility (r = -0.656; p = 0.006 and r = -0.604; p = 0.013) and chest expansion (r = -0.502; p = 0.047 and r = 
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The Journal of on April 2, 2020 -Published by www.jrheum.org Downloaded from -0.613; p = 0.012) and positively correlated with wall-occiput distance (r = 0.509; p = 0.044 and r = 0.614; p = 0.011; Table 3 ). FMD did not correlate with any functional or metric measurements (data not shown).
As an internal control, the widely used disease activity scale BASDAI strongly correlated with the patient's assessment of activity on VAS (r = 0.922; p = 0.0001), indicating that patient's VAS may be a simple and useful assessment tool in this respect. However, none of the vascular measurements showed any correlation with disease activity markers, such as BASDAI, ESR, CRP, or patient's assessment of activity on VAS (data not shown). Further, no significant associations were observed in patients with AS among FMD, ccIMT, or PWV values in comparison to sex distribution, drug treatment modalities, BMI, HLA-B27 status, current smoking, or patient's assessment of pain on VAS (data not shown).
DISCUSSION
Cardiovascular and cerebrovascular diseases are major causes of morbidity and mortality in the general population, as well as in autoimmune-inflammatory diseases 1, 2, 4, 5 . Early identification of patients with higher risk for vascular disorders allows us to introduce primary prevention or effective pharmacological treatment. Assessing risk for future vascular events involves measuring FMD, overt ccIMT, and PWV 25, 26, 32, 33, 34 . There have been numerous recent studies showing increased ccIMT and PWV as well as impaired FMD in RA 2, 3, 25, 26, 34, 35, 36, 37, 38 .
There have been relatively few and somewhat controversial data regarding vascular function in AS 23 . Most recent studies separately assessed FMD, ccIMT, or PWV in AS. Sari, et al 17 and Pieringer 15 found impaired FMD in AS. We also found impaired FMD in 43 patients with AS in comparison to controls. In addition, decreased FMD correlated with increased ccIMT in AS. We found no associations between FMD and functional or metric measurements of AS, suggesting that FMD is a "snapshot" of endothelial function, while structural and functional damage of the musculoskeletal system occurs after many years.
Most groups, including Sari, et al 17 , Malesci, et al 12 , and Choe, et al 6 , did not find any differences in ccIMT between AS and control groups. These AS cohorts consisted of 26-28 patients. Gonzalez-Juanatey, et al 7 reported more carotid plaques, but unchanged ccIMT in AS. In contrast, similar to our results, Mathieu, et al 13 and Peters, et al 8 found significantly higher ccIMT in AS compared to controls. In the latter study, more than 50 patients with AS were recruited. We also report significantly increased ccIMT in AS compared to controls. Our results are similar to those published by Peters, et al 8 . Further studies are needed to come to a decision regarding carotid atherosclerosis in AS. Regarding possible correlations, ccIMT correlated with impaired FMD and increased aortic stiffness and also correlated with disease duration, BASFI, and metric measurements including lumbar spine mobility, chest expansion, and wall-occiput distance. Other investigators assessing ccIMT did not report associations of ccIMT with any of these functional or metric measurements. Our results indicate that the development of atherosclerosis occurs over a longer period of time and is associated with longer duration of AS and the development of more severe structural and functional disability.
There have been absolutely no data on PWV. Choe, et al 6 reported normal elasticity while Moyssakis, et al 28 found impaired elasticity in AS. Mathieu, et al 13 found nonsignificant increase of AIx in AS compared to controls. Our study is the first showing PWV data in AS. PWV may be the most widely determined and most reliable indicator of arterial stiffness 26, 39 . We found significantly increased aortic stiffness indicated by increased PWV in patients with AS compared to healthy controls. Moreover, PWV correlated with ccIMT, as well as with age, disease duration, BASFI, and all metric measurements described. Thus, aortic stiffness, similarly to carotid atherosclerosis, develops in parallel with the progression of AS. Further, because PWV was correlated with ccIMT, increased stiffness may be a consequence of atherosclerosis.
There have been reports on endothelial dysfunction, carotid atherosclerosis, and arterial stiffness in AS. However, all investigator groups assessed FMD, ccIMT, or stiffness separately. Only Sari, et al 17 
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The Journal of on April 2, 2020 -Published by www.jrheum.org Downloaded from with those published in the only available larger AS study, performed by Sari, et al 17 . There have been controversies regarding ccIMT studies. While normal ccIMT was found in some studies, one of the most recent reports by Peters, et al 8 , as well as our study, described increased ccIMT in AS. This controversial issue needs to be studied further. Regarding stiffness, we are the first group that assessed PWV rather than elasticity or AIx in AS. PWV has become the most reliable marker of vascular stiffness in recent studies 26, 35, 40, 41 . Therefore, ours is the first study that assessed FMD, ccIMT, and PWV simultaneously, in the same AS cohort. In addition, we performed extensive correlation analysis in the patients with AS. Endothelial dysfunction indicated by impaired FMD may be a transient, short-term event that may precede overt atherosclerosis and vascular disease. Thus, FMD could not be correlated with disease duration and chronic disability resulting from AS. In contrast, we are the first to report significant correlations between carotid atherosclerosis and aortic stiffness with AS disease duration and functional and metric impairment. None of the assessed vascular measurements correlated with any markers of disease activity in AS.
The strength of our study is that we include 3 noninvasive techniques to detect endothelial function, atherosclerosis, and stiffness in the same AS population. Further, we correlated these markers with numerous clinical and laboratory measurements. A limitation of our study could be the relatively low patient number, although even smaller cohorts were studied by others. We also cannot fully exclude the possible confounding effects of medications, such as NSAID or anti-TNF biologics.
Thus, patients with AS may be screened for atherosclerosis and subclinical vasculopathy using these noninvasive techniques. Patients at high risk should undergo primary or secondary prevention. Statins might be beneficial for patients with AS 18 . There have been many reports on the possible vasculoprotective effects of anti-TNF biologics in RA 42, 43 . Reports have suggested that TNF blockade might improve dyslipidemia and microvascular function in AS 19, 20 . Ten evidence-based recommendations for the cardiovascular management of RA, AS, and patients with psoriatic arthritis have been developed by a European League Against Rheumatism task force 3 . It is recommended that every effort should be made to identify high-risk patients early. Moreover, the aggressive suppression of systemic inflammation by DMARD or biologics may also lower the risk for vascular diseases in AS 3 .
